NAGD regimen for the coma of drug-related overdose.
A specific arousal therapy with NAGD (Naloxone, Activated Charcoal, Glucagon, Doxapram) is outlined for victims of drug overdose in comatose and semi-comatose states. Several direct benefits accrue if early awakening or lightening of such patients is safely accomplished. There are: 1) elimination of need for prolonged intubation or tracheostomy; 2) patient's ability to tell which drug(s) were taken; 3) excessively frantic and vigorous supportive treatment is obviated; and 4) the overall hospital stay is shortened. The NAGD regimen has been found to effectively, safely, and predictably reverse coma. Therapy consists of: naloxone 0.8 mg to 1.6 mg intravenously; large-bore orogastric tube instillation of 100 gm to 120 gm activated charcoal slurry; glucagon 1 mg to 2 mg intravenously; and, in selected cases, doxapram 1 mg/kg to 2 mg/kg intravenously.
D002606:Charcoal / Q000008:administration & dosage* / Q000494:pharmacology; D003128:Coma / Q000139:chemically induced / Q000188:drug therapy*; D004315:Doxapram / Q000008:administration & dosage* / Q000494:pharmacology; D004359:Drug Therapy, Combination; D005934:Glucagon / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D009270:Naloxone / Q000008:administration & dosage* / Q000494:pharmacology; D019966:Substance-Related Disorders / Q000150:complications*
D002606:Charcoal; D009270:Naloxone; D005934:Glucagon; D004315:Doxapram